Clinical Trials
14 trialsNCT01351545 2026-04-13
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Center for International Blood and Marrow Transplant Research
Recruiting
NCT04645199 2026-02-12
NICHE
Institute of Hematology & Blood Diseases Hospital, China
Recruiting
NCT01199562 2026-01-28
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
City of Hope Medical Center
Active not recruiting
NCT01137643 2025-10-27
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
UNC Lineberger Comprehensive Cancer Center
Recruiting
NCT03016806 2025-10-10
Umbilical Cord Blood Transplantation From Unrelated Donors
University of Rochester
Recruiting
NCT07205523 2025-10-03
HALO-SCT
Affiliated Hospital of Qinghai University
Recruiting
NCT07145411 2025-08-28
HOPE
Ossium Health, Inc.
Recruiting
NCT06335277 2024-03-28
Total Body Irradiation Treatments for Patients Treated at European Institute of Oncology
European Institute of Oncology
Unknown
NCT00900120 2021-09-21
Collecting and Storing Blood Samples From Patients With Cancer
Rutgers, The State University of New Jersey
Withdrawn
NCT00510315 2020-12-07
Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Cancer or a Related Illness Following Total Body Irradiation and Stem Cell Transplant
Memorial Sloan Kettering Cancer Center
Completed
NCT00964821 2017-11-07
Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant
City of Hope Medical Center
Completed
NCT00993694 2017-04-17
Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone
Vanderbilt University Medical Center
Completed
NCT00569842 2014-09-11
Investigation of the Cylex® ImmuKnow® Assay
Indiana University
Completed
NCT00513175 2012-11-09
Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia
University of California, San Francisco
Completed